Literature DB >> 26402313

Psychopharmacological Management of Problem Behaviors in Mowat-Wilson Syndrome.

Aaron D Besterman1, Robert L Hendren1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26402313      PMCID： PMC4615772          DOI： 10.1089/cap.2015.0107

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  4 in total

Review 1.  Practitioner review: Psychopharmacology in children and adolescents with mental retardation.

Authors:  Benjamin L Handen; Richard Gilchrist
Journal:  J Child Psychol Psychiatry       Date:  2006-09       Impact factor: 8.982

2.  The behavioral phenotype of Mowat-Wilson syndrome.

Authors:  Elizabeth Evans; Stewart Einfeld; David Mowat; John Taffe; Bruce Tonge; Meredith Wilson
Journal:  Am J Med Genet A       Date:  2012-01-13       Impact factor: 2.802

3.  Clinical features and management issues in Mowat-Wilson syndrome.

Authors:  Margaret P Adam; Susan Schelley; Renata Gallagher; April N Brady; Kimberly Barr; Bruce Blumberg; Joseph T C Shieh; John Graham; Anne Slavotinek; Madelena Martin; Kim Keppler-Noreuil; Andrea L Storm; Louanne Hudgins
Journal:  Am J Med Genet A       Date:  2006-12-15       Impact factor: 2.802

4.  Sip1 regulates sequential fate decisions by feedback signaling from postmitotic neurons to progenitors.

Authors:  Eve Seuntjens; Anjana Nityanandam; Amaya Miquelajauregui; Joke Debruyn; Agata Stryjewska; Sandra Goebbels; Klaus-Armin Nave; Danny Huylebroeck; Victor Tarabykin
Journal:  Nat Neurosci       Date:  2009-10-18       Impact factor: 24.884
  4 in total
  1 in total

Review 1.  Neurological Phenotype of Mowat-Wilson Syndrome.

Authors:  Duccio Maria Cordelli; Veronica Di Pisa; Anna Fetta; Livia Garavelli; Lucia Maltoni; Luca Soliani; Emilia Ricci
Journal:  Genes (Basel)       Date:  2021-06-27       Impact factor: 4.096
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.